Market Place
Sourcing Support
All News #Library
Rare Diseases
Boehringer Ingelheim`s Apecotrep Reduces Proteinuria In Phase II
28 Jan 2026 //
GLOBENEWSWIRE
FDA Approves JASCAYD Tablets For Progressive Pulmonary Fibrosis
22 Dec 2025 //
PR NEWSWIRE
FDA Approves JASCAYD Tablets For Progressive Pulmonary Fibrosis
19 Dec 2025 //
GLOBENEWSWIRE
JASCAYD Gains First Approval for Pulmonary Fibrosis in China
10 Dec 2025 //
GLOBENEWSWIRE
Boehringer Ingelheim Picks Orsini as Jascayd Specialty Pharmacy
14 Oct 2025 //
PR NEWSWIRE
Boehringer Breaks IPF Treatment Drought with New FDA approval
09 Oct 2025 //
FIERCE PHARMA
Leo Ponies up €90 Million for Boehringer Ingelheim`s Spevigo
15 Jul 2025 //
BUSINESSWIRE
BI’s SPEVIGO wins 2023 Prix Galien USA Best Rare Diseases Solution Award
27 Oct 2023 //
BUSINESSWIRE
Boehringer eyes rare disease use for respiratory blockbuster
21 May 2019 //
PMLIVE
Promethera Raises Euro 10M in a Series C-extension Financing
28 Oct 2016 //
BUSINESS WIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.